Research Papers:

PIWIL2 induces c-Myc expression by interacting with NME2 and regulates c-Myc-mediated tumor cell proliferation

Youlin Yao, Chao Li, Xiaoyan Zhou, Yu Zhang, Yilu Lu, Jianhui Chen, Xulei Zheng, Dachang Tao, Yunqiang Liu and Yongxin Ma _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2014; 5:8466-8477. https://doi.org/10.18632/oncotarget.2327

Metrics: PDF 3022 views  |   HTML 2854 views  |   ?  


Youlin Yao1,*, Chao Li1,*, Xiaoyan Zhou1,*, Yu Zhang1, Yilu Lu1, Jianhui Chen1, Xulei Zheng1, Dachang Tao1, Yunqiang Liu1 and Yongxin Ma1

1 Department of Medical Genetics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China

* These authors contributed equally to this work


Yongxin Ma , email:

Keywords: PIWIL2, c-Myc, NME2, Proliferation, F-actin

Received: May 20, 2014 Accepted: August 07, 2014 Published: August 08, 2014


c-Myc serves as a crucial regulator in multiple cellular events. Cumulative evidences demonstrate that anomalous c-Myc overexpression correlates with proliferation, invasion and metastasis in various human tumors. However, the transcriptionally activating mechanisms responsible for c-Myc overexpression are complex and continue to be intangible. Here we showed that Piwi-Like RNA-Mediated Gene Silencing 2 (PIWIL2) can upregulate c-Myc via binding with NME/NM23 nucleoside diphosphate kinase 2 (NME2). PIWIL2 promotes c-Myc transcription by interacting with and facilitating NME2 to bind to G4-motif region within c-Myc promoter. Interestingly, in a c-Myc-mediated manner, PIWIL2 upregulates RhoA, which in turn induces filamentary F-actin. Deficiency of PIWIL2 results in obstacle for c-Myc expression, cell cycle progress and cell proliferation. Taken together, our present work demonstrates that PIWIL2 modulates tumor cell proliferation and F-actin filaments via promoting c-Myc expression.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 2327